DIA Biosimilars 2013

Express Scripts

AmerisourceBergen signs 3 year supply agreement with Express Scripts

Thursday, August 2, 2012 09:56 AM

AmerisourceBergen, a global pharmaceutical services company based in Valley Forge, Penn., has signed a three year agreement to supply approximately $18.5 billion in pharmaceuticals to Express Scripts on an annual basis, effective October 1, 2012.

More... »

Cenduit: Now with Patient Reminders

FDA approves first-ever med for Cushing’s syndrome

Friday, February 24, 2012 11:14 AM

The FDA has approved Korlym (mifepristone) 300mg tablets as a once-daily oral medicine to control hyperglycemia secondary to hypercorisolism in adults with endogenous Cushing’s syndrome, according to Corcept Therapeutics.

More... »

CRF Health – eCOA Forum

Medco shareholders approve merger with Express Scripts

Thursday, December 22, 2011 12:48 PM
Shareholders of Medco Health Solutions have approved a proposed merger with Express Scripts.

More... »

Express Scripts to buy Medco Health Solutions for $29 billion

Thursday, July 21, 2011 12:52 PM

Express Scripts will buy rival Medco Health Solutions, parent company of United BioSource Corp., for $29.1 billion, creating a U.S. powerhouse in managing prescription drug benefits, the companies said, according to Reuters.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs